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Abstract
Neutrophils are involved in the pathogenesis of acute lung injury. The neutrophil-derived enzyme myeloperoxidase (MPO)
catalyzes the formation of the oxidant hypochlorous acid (HOCl). This study characterizes the effects of (A) continuous
HOCl infusion, and (B) stimulated neutrophils on pulmonary circulation in an isolated rabbit lung model. Furthermore, the
effect of cyclooxygenase inhibition by acetylsalicylic acid (ASA, 0.5 mM) on these effects was investigated. (A) Infusion of
HOCl (in nmol min31, groups: 0, 0+ASA, 1000, 1000+ASA, 2000, and 2000+ASA) into the isolated organ was started after
a 45-min steady-state period (t = 0). (B) Neutrophils (PMN group: 1480 þ 323 and ASA group 1294 þ 320 Wl31) were added
into the perfusate between (t =345 min) and stimulated with FMLP (1 WM) after two 45-min steady-state periods (t = 0).
Perfusate MPO activity was measured at t =390, 345, 0, 1, 2, 3, 5, 10, 15, 30, 60, and 90 min. For both groups, pulmonary
artery pressure (PAP) and lung weight were continuously recorded and the capillary filtration coefficient (Kf;c in 1034 cm3 s31
cm H2O31 g31) was calculated from the slope of weight gain after a hydrostatic challenge at t =345, 315, 30, 60 and 90 min.
(A) Continuous HOCl infusion (1000/2000 nmol min31) evoked a significant increase in vPAP and an up to 10-fold increase
in Kf;c reaching the maximum extent of the observed effects significant earlier in the 2000 nmol min31 group. ASA reduced
vPAPmax significantly to about 50% in corresponding groups and the increase in PAP and Kf ;c occurred later in the ASA
groups. (B) Neutrophil stimulation (PMN group/ASA group) evoked a rapid increase in vPAP and MPO activity, while the
changes in vascular permeability were rather moderate, but still significant. The release of MPO activity was similar in both
groups. ASA significantly reduced the increase in vPAP without affecting the release of MPO activity. Compared to baseline
values, the preventive effects on vascular permeability increase reached level of significance as well. In summary, the
described changes in pulmonary circulation caused by HOCl infusion or by neutrophil stimulation are significantly reduced
by ASA. An involvement of cyclooxygenase products in the mediation of neutrophil-derived oxidative stress could be
concluded. ß 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
Neutrophils play a crucial role in many in£amma-
tory a¡ections of the lung, especially in acute lung
injury [1,2]. The sticking of large numbers of neutro-
phils in the pulmonary microvasculature is one of the
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initiating events in the adult respiratory distress syn-
drome (ARDS) [3], and is accompanied by a remark-
able increase in the count of neutrophils and of mye-
loperoxidase (MPO) activity in the bronchioalveolar
lavage £uid [3,4]. Although ARDS is also observed
in neutropenic patients and in leukocyte free animal
models [5], neutrophils are regarded as key cells for
aggravation and perpetuation of pulmonary in£am-
matory events [6]. Activated neutrophils a¡ect sur-
rounding lung tissue via several potentially patho-
genic cellular mechanisms including the release of
lysosomal proteolytic enzymes, [2,7], the production
of prostanoids [7,8], and the generation of highly
reactive oxygen radicals and intermediates [7,9^11].
Several highly reactive metabolites are released
during the respiratory burst of stimulated neutrophils
(for review see [11,12]). The superoxide radical that is
generated from the membrane-associated NADPH-
oxidase dismutates spontaneously, and enzymati-
cally, and forms hydrogen peroxide. Subsequently,
the hem-enzyme MPO that is released from stimu-
lated neutrophils catalyzes the formation of hypo-
chlorous acid (HOCl) from hydrogen peroxide and
chloride [13]. HOCl is a main product of stimulated
neutrophils. It is much more reactive than hydrogen
peroxide [14]. Whereas oxygen radicals cause lipid
peroxidation of the liquid phase of the cell mem-
brane, which leads to a non-speci¢c increase in the
membrane permeability and cell damage, HOCl as a
non-radical oxidant causes oxidative modi¢cation of
free functional groups [15] and subsequently func-
tional alterations of proteins [16]. Therefore, HOCl,
which is not expected to cause non-speci¢c e¡ects or
cell damage due to lipid peroxidation, is a useful
model to investigate pharmacological actions of ox-
idative stress. Highly reactive oxygen metabolites are
also released by other sources than neutrophils, es-
pecially by endothelial cells, which generate superox-
ide radicals or hydrogen peroxide [17,18]. HOCl,
however, is a neutrophil-speci¢c oxidant, because
its formation is dependent on neutrophil-released
MPO, and, therefore, it can be used as a speci¢c
model for neutrophil-derived oxidative stress. HOCl
has been shown to evoke e¡ects on pulmonary mi-
crovasculature [19] as well as on the oxidative state
of free functional groups of proteins [15] that are
comparable to those of stimulated neutrophils [15].
Eicosanoids play a crucial role in pulmonary path-
ophysiology during acute lung injury as well (for
review [20]). Cyclooxygenase products with vasocon-
strictive and vasodilatatory properties are predomi-
nantly implicated in the regulation of pulmonary
vascular tone. Thromboxan (TX) A2 and prostaglan-
din (PG) I2 (prostacyclin) cause a net rise in pulmo-
nary artery pressure (PAP) with augmented shunt
£ow [21]. Inhibitors of cyclooxygenase and TX-syn-
thase have been shown to reduce signi¢cantly these
e¡ects in several experimental models [22,23]. 5-Lip-
oxygenase products, i.e. the peptido leukotrienes
(LT) LTC4, LTD4 and LTE4 are reported to cause
changes in vascular permeability with subsequent
formation of protein rich, interstitial edema [24,25].
Neutrophil-derived oxidant and eicosanoid gener-
ation and pulmonary eicosanoid metabolism during
acute lung injury are closely interrelated. The gener-
ation of the vasoactive LTC4, LTD4 and LTE4 [24]
requires the cooperation between neutrophils that
release LTB4 themselves, but lack the enzyme gluta-
thione transferase and other compartments, i.e. en-
dothelial cells [26]. Neutrophil-derived LTB4 aggra-
vates the in£ammatory response additionally,
initiating adhesion and migration of neutrophils
into the vascular interstitium by its strong chemotac-
tic e¡ect [27]. Furthermore, there is some evidence
that oxidative stress may activate pulmonary arach-
idonic acid (AA) metabolism predominantly via cy-
clooxygenase pathways [28,29].
Su⁄cient data characterize the isolated e¡ects of
several oxidants (for example [14,17]) or of eicosa-
noids on pulmonary microcirculation [24,30]. There
are also data that describe the pulmonary release of
TX due to application of oxidants [23,28]. Less in-
formation is available concerning the e¡ect of cyclo-
oxygenase inhibition on oxidant-induced changes in
the pulmonary microcirculation in these models of
oxidative stress-induced acute lung injury.
First, this study characterizes the e¡ect of contin-
uous administration of HOCl and of stimulation of
neutrophils sequestrated in the pulmonary microvas-
culature on PAP and vascular permeability. Second,
it investigates the in£uence of cyclooxygenase inhib-
ition on these models of oxidative stress-induced lung
injury. Finally, the inhibitory e¡ects of cyclooxyge-
nase inhibition in both models are compared to asses
the reproducibility of neutrophil-derived oxidative
stress by HOCl infusion.
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2. Materials and methods
2.1. Substances
Acetylsalicylic acid (ASA) was purchased from
Bayer (Leverkusen, Germany). Sterile, pyrogen free
Krebs^Henseleit bu¡er solution (KHB) was obtained
from Serag-Wiesner (Naila, Germany). All other bi-
ochemical reagents were obtained from Sigma (Mu-
nich, Germany) and were used in p.a. quality. The
concentration of the HOCl stock solution was deter-
mined spectrophotometrically (O290 nm = 350 mol31
cm31) immediately before use according to Morris
[13].
2.2. Isolated rabbit lung model: general procedure
Preparation of isolated rabbit lungs was performed
using the method described in detail by Seeger et al.
[30]. In short, rabbits of either sex between 2.5 and
3.5 kg body weight (BW) were used. The animals
were deeply anesthesized with a mixture of ketamine
base and xylazine (30 mg/27 mg) and anticoagulated
with 1000 U heparin kg31. The rabbits were venti-
lated after tracheotomy with 4% CO2, 17% O2 and
79% N2 (tidal volume, 30 ml; frequency, 30 min31).
Thoracotomy was performed and a wide-bore can-
nula was inserted under £ow into the pulmonary
artery via the right ventricular out£ow tract. Ice-
cold KHB was used for perfusion with an initial
£ow of 10^20 ml min31 in order to avoid possible
biochemical events stimulated by the change of per-
fusion £uid. After removal from the thorax, the
lungs were placed in a 4‡C equilibrated chamber,
freely suspended from a force transducer. A second
cannula was placed in the left ventricle and the left
atrium was ligated. In combination, the temperature
of the perfusion £uid and of the housing chamber as
well as the perfusion £ow were gradually increased
within 20 min. The de¢nite £ow rate was set 100 ml
min31 with recirculation of the bu¡er medium (total
circulating volume, 300 ml) after extensive rinsing of
the vascular bed. Formaldehyde sterilized perfusion
circuit tubing and endotoxin free bu¡er £uids were
used throughout. The endotoxin content of the recir-
culating perfusate was repeatedly measured in pre-
vious experiments and was always 6 10 pg ml31 (de-
tection limit of the used test) [31]. The bu¡er con-
tained (mM) 132.8 NaCl, 5.2 KCl, 1.1 KH2PO4, 24.1
NaHCO3, 2.4 CaCl, 1.3 MgPO4 and (mg ml31) 240
glucose. Perfusate temperature was set 37‡C. The pH
of the perfusion £uid was held constant between 7.35
and 7.45. PAP, pulmonary venous pressure (PVP,
measured in the left ventricle), in£ation pressure
and the weight gain of the isolated organ were con-
tinuously registered. After a steady-state period of 45
min, including a hydrostatic challenge at t =315
min, only those lungs were selected for the study
that showed no signs of leakage at the catheter in-
sertions sights, that had a homogenous white appear-
ance with no signs of edema formation, that had lost
weight during the phase of temperature increase, and
that were completely isogravimetric during the
steady-state period. After steady state, the PAP
ranged between 7 and 11 torr. The inspiratory peak
in£ation pressure was set at 7^9 torr and ventilation
was performed with a PEEP of 1 cm water column.
The PVP was adjusted to 2 torr. Perfusion £uid was
exchanged by fresh bu¡er solution immediately be-
fore stimulation, using two separate perfusion cir-
cuits alternately.
2.3. Gravimetric estimation of Kf ;c
Capillary ¢ltration coe⁄cient (Kf ;c) was deter-
mined gravimetrically from the slope of lung weight
gain after a sudden venous pressure elevation of
7.5 torr (= 10 cm water column) for 8 min [32]. Per-
fusion and ventilation were not interrupted during
this time. The slow phase of weight gain was taken
to begin 2 min after increase in venous pressure [33].
Time zero extrapolation of the slope of weight gain
curve was performed using a semi-logarithmic plot of
the rate of lung weight gain (vW vt31) [34]. Kf ;c was
calculated from the change in vW vt31 induced by
the disturbance of £uid balance according to hydro-
static challenge and was related to wet weight lung
(WWL) that was calculated from the BW using
WWL = BWU0.0024 [35]. [Kf ;c] was given as 1034
ml s31 cm H2O31 g31.
2.4. Estimation of vascular compliance
Total vascular compliance (C) is de¢ned as the
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change in vascular volume per change in microvas-
cular pressure. The total rapid change in weight over
the ¢rst 1^2 min after onset of the venous pressure
challenge was taken as pure vascular ¢lling and used
for the calculation of compliance [32]. Therefore, the
tangent to the slope of weight gain 2 min after onset
of the pressure rise was elongated to the time zero of
pressure increment to correct for the £uid ¢ltration
during the ¢rst 2 min [30]. [C] was given in g cm
H2O31.
2.5. Estimation of total £uid retention
The total £uid retention (vW) was determined as
remaining di¡erence of weight before and after a
hydrostatic challenge corresponding to the remaining
interstitial £uid ¢ltered during hydrostatic challenge
after normalization of venous pressure and equilibra-
tion of a new £uid balance. [vW] was given in g.
2.6. Preparation of neutrophils
Human neutrophils were isolated from freshly
drawn heparinized (10 IU ml31) venous blood of
normal volunteers. The preparation included dex-
tran-enhanced sedimentation, Ficoll-density centrifu-
gation, and osmotic lysis of remaining erythrocytes
with distilled water. PMN were washed twice and
suspended in Hank’s balanced salt solution. The
preparation of neutrophils was about 98% pure and
viable and the cells were used at least within 60 min
after preparation.
2.7. Experimental protocol
Two models of oxidative stress-induced lung injury
were used: continuous infusion of HOCl, and stim-
ulation of neutrophils after having been delayed in
the pulmonary microvasculature.
2.7.1. Continuous application of HOCl
The continuous application of HOCl into the ar-
terial line of the system was started at t = 0 min after
a 45-min steady-state period including a baseline hy-
drostatic challenge at t =315 min. HOCl, which was
diluted with perfusate in di¡erent concentrations,
was infused with a constant £ow rate of 0.5 ml
min31, so that HOCl doses of 1000 and 2000 nmol
min31 were administered. Perfusate contained
500 WM ASA (ASA groups) or no inhibitor (non-
ASA groups). Hydrostatic challenges were performed
at 30, 60, and 90 min. The results were compared
with a control group with continuous saline applica-
tion.
2.7.2. Stimulated neutrophils
Perfusate contained 500 WM ASA (ASA group) or
no inhibitor (PMN group). Neutrophils were injected
into the arterial line of the preparation at t =345 min
between two 45-min steady-state periods, including
two baseline hydrostatic challenges at t =360 and
t =315 min. The number of neutrophils added to
the perfusate was related to the whole circulating
volume and given as cells Wl31. Cell counts with-
drawn from the venous line indicated that the ma-
jority of the PMNs (about 95%) was sequestrated in
the lung after the ¢rst passage. The neutrophils were
activated by addition of the chemotactic tripeptide
FMLP in a ¢nal concentration of 1 WM into the
perfusate at t = 0 min. Samples for MPO activity
measurement were taken at t =390, 345, 0, 1, 2,
3, 5, 10, 15, 30, 60 and 90 min. Hydrostatic chal-
lenges were performed at t = 30, 60, and 90 min as
well. The results were compared with control groups
either with neutrophil addition without subsequent
FMLP injection (group C-PMN), or with FMLP
injection without prior neutrophil addition (group
C-FMLP).
Potassium concentration and lactate dehydroge-
nase (LDH) activity were measured immediately be-
fore hydrostatic challenges in both protocols to show
that no cell damage occurred.
2.8. Analytical methods
Concentrations of potassium and LDH activity
were measured by clinical routine methods at the
institute of clinical chemistry of the University of
Go«ttingen using an Hitachy 747 multi-analyzer
with commercially available test kits (Boehringer
Mannheim, Germany).
The MPO activity was assayed according to the
method described by Klebano¡ et al. [36]. Brie£y, a
sample of 100 Wl was added to 2.9 ml assay solution.
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This solution was made up daily as follows: 26.9 ml
H2O, 3.0 ml 0.1 M sodium phosphate bu¡er, 0.1 ml
0.1 M H2O2 and 0.048 ml guaiacol. The production
of tetra-guaiacol was spectrophotometrically meas-
ured at 470 nm (O= 26.6 mM31 cm31) for 5 min.
One unit (U) was de¢ned as the enzymatic activity
that consumes 1 mmol hydrogen peroxide per mi-
nute.
2.9. Statistical methods
Data are given as mean þ standard error of means
(S.E.M.). Analysis for statistical signi¢cance of time^
pressure curves was performed by one-way analysis
of variance (one-way ANOVA). For all other calcu-
lations, the two-tailed Student’s t-test for unpaired
samples was used. Signi¢cance was assumed at
P9 0.05 for both.
3. Results
3.1. Continuous HOCl infusion
There was no signi¢cant di¡erence in baseline PAP
between all groups. The upper traces of Fig. 1 dem-
onstrate the time course of vPAP. Infusion of saline
did not evoke any pressure response in control ex-
periments with and without addition of ASA. HOCl
evoked a dose-dependent increase in vPAP. The
maximum vPAP (vPAPmax) occurred earlier in the
2000 nmol min31 than in the 1000 nmol min31
group. No di¡erence between these groups was
found in the maximal extent of the pressure increase,
as edema formation occurred earlier in 2000 nmol
min31 than in the 1000 nmol min31 group and pre-
vented a further continuation of the pressure in-
crease. ASA in a ¢nal perfusate concentration of
Fig. 1. E¡ect of ASA on HOCl-induced increase in PAP: the time course of the vPAP (upper traces) and the time of vPAPmax (lower
traces) in response to continuous HOCl-infusion (open symbols, without ASA; closed symbols, with 500 WM ASA perfusate concen-
tration) are given. Data represent mean þ S.E.M. *P6 0.05 vs. corresponding data without ASA.
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500 WM reduced signi¢cantly this HOCl-induced
pressure response in both groups. The extent of pres-
sure increase was reduced to about 50% of the value
without ASA. The start of pressure increase as well
as the vPAPmax occurred later in the ASA groups
than in the corresponding non-ASA groups.
Table 1 summarizes the results calculated from the
hydrostatic challenges (vW, Kf ;c and C). In control
experiments with saline infusion, no changes in these
parameters were found during the whole recording
time of 105 min. The HOCl-induced increase in
Kf ;c and in £uid retention during hydrostatic chal-
lenges is dose dependent as well. Severe edema for-
mation (total £uid retention [vWtot]s 50 g) caused
premature termination of the experiments after
83.7 þ 5.4 min and after 39.4 þ 5.2 min in the 1000
and the 2000 nmol min31 HOCl group, respectively.
The Kf ;c, the increase in £uid retention, and the ede-
ma formation indicate a remarkable HOCl-induced
vascular leakage. ASA attenuates these HOCl-in-
duced e¡ects on Kf ;c and vW. The HOCl-induced
changes occur later, the whole recording time is sig-
ni¢cantly longer, and the total increase in Kf ;c and
vW at t = 30 or 60 min is signi¢cantly reduced in
both ASA groups. As PAP did not exceed 18 torr,
the formation of hydrostatic edema would not be
expected [30]. The vascular compliance is found to
remain unchanged during HOCl administration, in-
dicating that the increase in lung weight is due rather
to changes in the microvascular permeability than to
increased vascular ¢lling. Perfusate concentrations of
potassium and LDH activity (data not shown) show
no signi¢cant changes either, implying that the ob-
served e¡ects are not caused by non-speci¢c cell
damage.
3.2. Neutrophil stimulation
Table 2 and Fig. 2 demonstrate the results of the
experiments with stimulated neutrophils. Human
neutrophils (PMN group, 1480 þ 323 Wl31 ; ASA
group, 1294 þ 320 Wl31 ; and C-PMN group,
Table 1
Hydrostatic challenges of experiments with HOCl administration
HOCl (nmol min31) Duration (min) Hydrostatic challenge
Baseline (t =315 min) 1st (t = 30 min) 2nd (t = 60 min) 3rd (t = 90 min)
Kf ;c (1034 cm3 s31 m H2O31 g31)
0 (n = 6) 105 0.73 þ 0.077 0.70 þ 0.081 0.75 þ 0.085 0.72 þ 0.088
0+ASA (n = 4) 105 0.86 þ 0.091 0.78 þ 0.10 0.82 þ 0.12 0.83 þ 0.063
1000 (n = 6) 83.7 þ 5.4 0.71 þ 0.088 0.92 þ 0.12 7.42 þ 1.50
1000+ASA (n = 5) 105a 0.97 þ 0.052 1.05 þ 0.10 1.22 þ 0.25a s 10.0
2000 (n = 4) 39.4 þ 5.2 0.84 þ 0.140 s 10.00
2000+ASA (n = 5) 58.5 þ 3.2a 0.99 þ 0.14 0.77 þ 0.07a
vWtot (g) vW (g)
0 (n = 6) 2.5 þ 0.05 0.7 þ 0.13 1.0 þ 0.15 0.8 þ 0.09 0.7 þ 0.11
0+ASA (n = 4) 2.2 þ 0.03 0.7 þ 0.09 0.8 þ 0.017 0.8 þ 0.03 0.6 þ 0.08
1000 (n = 6) s 50.0 0.9 þ 0.23 1.4 þ 0.10 30.8 þ 7.76
1000+ASA (n = 5) s 50.0 1.1 þ 0.29 1.3 þ 0.38 2.0 þ 0.63a s 35.0
2000 (n = 4) s 50.0 1.5 þ 0.33 s 35.0
2000+ASA (n = 5) s 50.0 0.7 þ 0.14 1.3 þ 0.22a
C (g cm H2O31)
0 (n = 6) 0.35 þ 0.02 0.33 þ 0.04 0.34 þ 0.02 0.34 þ 0.03
0+ASA (n = 4) 0.31 þ 0.04 0.29 þ 0.05 0.28 þ 0.04 0.26 þ 0.03
1000 (n = 6) 0.39 þ 0.03 0.38 þ 0.02 0.30 þ 0.01
1000+ASA (n = 5) 0.32 þ 0.03 0.30 þ 0.02 0.29 þ 0.03 0.26 þ 0.02
2000 (n = 4) 0.41 þ 0.03 0.42 þ 0.12
2000+ASA (n = 5) 0.35 þ 0.02 0.32 þ 0.04
aP6 0.05 vs. corresponding value without ASA.
BBADIS 61759 9-10-98
H. Wahn, S. Hammerschmidt / Biochimica et Biophysica Acta 1408 (1998) 55^6660
1295 þ 426 Wl31) were added into the perfusate at
t =345 min between two baseline hydrostatic chal-
lenges. Cell counts withdrawn from the venous line
indicated that more than 95% of the cells disap-
peared from the perfusate within the ¢rst passage.
As indicated by the parameters of both baseline hy-
drostatic challenges (t =360 and t =315 min) and
by the time course of vPAP and MPO activity, ad-
dition of neutrophils into the perfusate caused no
changes in PAP and vascular permeability, but a
slight increase in MPO activity from 0 mU l31 to
about 10 mU l31. This increase may be explained
by MPO release due to cell damage during prepara-
tion of neutrophils. No di¡erences between control
groups, PMN group, and ASA group are observed
under baseline conditions.
Neutrophil stimulation evokes a rapid increase in
vPAP and MPO activity. Whereas the time course of
vPAP shows a short maximum after between 2.5 and
5 min and is almost totally reversible, the MPO ac-
tivity remains elevated in the range of the maximum
MPO activity over the whole recording time. ASA
signi¢cantly reduced the increase in vPAP without
a¡ecting the release of MPO activity. The slight, con-
tinuous increase in MPO activity without any
changes in vPAP that is found in the C-PMN group
(addition of neutrophils, without stimulation) may be
explained by continuous MPO release from the neu-
trophils due to mechanical stress. FMLP stimulation
evokes a slight increase in MPO activity and vPAP
in the C-FMLP group (no neutrophils, but FMLP
stimulation) that may result from stimulation of res-
ident rabbit neutrophils.
The changes in vascular permeability due to neu-
trophil stimulation (given in Table 2) are rather mod-
erate. The increase in Kf ;c and in vW that is found in
the PMN group at t = 60 min is signi¢cant versus the
t = 60 min values of both control groups, as well as
versus the t =315 min baseline value. This about
80% increase in Kf ;c and vW from baseline to
t = 60 min may indicate a signi¢cant and relevant
increase in vascular permeability due to neutrophil
stimulation. The results of the ASA group are not
unambiguous. On the one hand, the 20^30% increase
in Kf ;c and vW after 30^90 min compared to baseline
does not reach P6 0.05 level of signi¢cance. ASA
apparently prevents an increase in vascular perme-
ability due to neutrophil stimulation. On the other
Table 2
Hydrostatic challenges of experiments with stimulated PMN
Duration (min) Hydrostatic challenge (min)
Baseline
t =345 min t =315 min 1st t = 30 min 2nd t = 60 min 3rd t = 90 min
Kf ;c (1034 cm3 s31 cm H2O31 g 1)
C-PMN (n = 4) 105.0 0.68 þ 0.071 0.73 þ 0.085 0.74 þ 0.088 0.72 þ 0.076 0.74 þ 0.089
C-FMLP (n = 4) 105.0 0.74 þ 0.065 0.71 þ 0.072 0.75 þ 0.077 0.77 þ 0.081 0.76 þ 0.085
PMN (n = 8) 105.0 0.70 þ 0.078 0.63 þ 0.115 0.89 þ 0.113 1.14 þ 0.17a;b 0.84 þ 0.121
ASA (n = 6) 105.0 1.14 þ 0.37 1.07 þ 0.21 1.25 þ 0.27b 1.35 þ 0.31b 1.15 þ 0.26b
vWtot (g) vW (g)
C-PMN (n = 4) 2.6 þ 0.21 0.9 þ 0.12 0.7 þ 0.09 0.6 þ 0.17 0.5 þ 0.10 0.7 þ 0.15
C-FMLP (n = 4) 2.2 þ 0.11 0.5 þ 0.08 0.5 þ 0.12 0.7 þ 0.19 0.6 þ 0.13 0.6 þ 0.11
PMN (n = 8) 2.1 þ 0.15 0.7 þ 0.15 0.6 þ 0.13 1.0 þ 0.27 1.1 þ 0.13a;b 0.9 þ 0.04
ASA (n = 6) 3.6 þ 0.8 0.9 þ 0.43 0.9 þ 0.26 1.2 þ 0.47 1.2 þ 0.29b 1.1 þ 0.12
Cell count
(Wl31)
C (g cm H2O31)
C-PMN (n = 4) 1295 þ 426 0.38 þ 0.068 0.37 þ 0.051 0.38 þ 0.057 0.39 þ 0.048 0.38 þ 0.053
C-FMLP (n = 4) no PMN 0.34 þ 0.042 0.33 þ 0.048 0.34 þ 0.052 0.35 þ 0.044 0.34 þ 0.029
PMN (n = 8) 1480 þ 323 0.45 þ 0.07 0.42 þ 0.056 0.41 þ 0.049 0.41 þ 0.041 0.42 þ 0.031
ASA (n = 6) 1294 þ 320 0.45 þ 0.07 0.45 þ 0.04 0.39 þ 0.06 0.42 þ 0.06 0.44 þ 0.05
aP6 0.05 versus t =315 min baseline value.
bP6 0.05 versus C-PMN and C-FMLP.
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hand, the absolute values of Kf ;c and vW of the ASA
groups under baseline conditions and during neutro-
phil stimulation are higher than in any other group.
The t = 30 to t = 90 min values of Kf ;c and vW of the
ASA group are signi¢cantly di¡erent from control
group values. No signi¢cant di¡erences were found
between the PMN group and the ASA group.
The maximum MPO activity (see Table 3) aver-
aged 56.1 þ 7.3 mU l31 in the PMN and 45.8 þ 7.18
mU l31 in the ASA group. These peak values were
measured in the 1-, 2- or 3-min sample. Fig. 3 (left
panel) shows a correlation between the number of
added cells and the maximum MPO activity after
neutrophil stimulation for both groups. The slope
Fig. 2. E¡ect of ASA on the increase in PAP and MPO perfusate activity induced by stimulated PMN: vPAP and MPO-activity of
all groups were measured at certain times and are given as mean þ S.E.M. The arrows indicate the addition of PMN into the perfusate
(¢rst arrow, t =345 min) and the addition of FMLP (second arrow, t = 0 min). *P6 0.05 vs. both control groups; 3P6 0.05 vs. PMN
group and both control groups.
Table 3
Comparison between PMN and ASA
PMN (n = 8) ASA (n = 6) P
Cell count 1480 þ 323 Wl31 1294 þ 320 Wl31 n.s.
MaximumMPO activity 56.1 þ 7.3 mU l31 45.8 þ 7.18 mU l31 n.s.
vPAPmax 8.4 þ 1.1 torr 4.2 þ 1.5 torr 0.05
TPAPmax 3.7 þ 0.19 min 4.1 þ 1.13 min n.s.
vKf ;c 81% 21% 0.05
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of the regression line of the ASA group is similar to
that of the PMN group. ASA does not reduce the
MPO activity that is released from stimulated neu-
trophils.
As demonstrated in Fig. 3 (right panel), the
vPAPmax of each single experiment correlates with
the corresponding maximum MPO activity. The
slope of the regression line of the ASA group is sig-
ni¢cantly lower than that of the PMN group. Similar
maximum perfusate MPO activities are accompanied
by di¡erent vPAPmax in the ASA and the PMN
groups. ASA inhibited the pressure increase partially
to about 50%.
4. Discussion
This study compares the e¡ects of cyclooxygenase
inhibition in two comparable models of lung injury
due to neutrophil-derived oxidative stress.
4.1. HOCl-induced lung injury and stimulated
PMN-induced lung injury
In addition to HOCl, several oxidants are released
during an oxygen burst of stimulated neutrophils,
i.e. superoxide anion radical, hydrogen peroxide, hy-
droxyl radical and singlet oxygen. Their ability to
evoke remarkable functional alterations or cell dam-
age, however, is limited for the following reasons:
(1) Superoxide anion radical dismutates spontane-
ously to hydrogen peroxide in a very rapid reaction
and is therefore not available in suitable quantities
for reactions with other targets. (2) Hydrogen per-
oxide is a stable oxidant. The majority of this oxi-
dant is consumed by neutrophils themselves to gen-
erate HOCl in a MPO-mediated reaction. For that
reason, only small quantities of hydrogen peroxide
are detectable in the extracellular pool [37]. (3) In
addition, the catalytic formation of hydroxyl radical
is prevented by the iron-binding lactoferrin that is
released by stimulated neutrophils [38]. In contrast
to these considerations, HOCl is a powerful oxidant,
which is generated in large quantities. Quantitative
analysis of neutrophil suspensions demonstrated that
106 maximal stimulated neutrophils produce about
2U1037 mol HOCl during 2 h [36]. Provided this
HOCl generation rate and the used total perfusate
volume of 300 ml, a neutrophil cell count of
2000 Wl31 is required to release 1000 nmol min31
Fig. 3. Correlation of cell count/MPO release and MPO release/vPAPmax : maximum MPO activity is plotted versus cell count and
vPAPmax is plotted versus maximum MPO activity for each single experiment of the PMN and ASA group. Regression lines, correla-
tion coe⁄cients (r) and levels of signi¢cance (P) are given.
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HOCl. This cell count would even represent a rather
low to normal value under physiological conditions.
Much higher cell counts are found during an in£am-
matory state, i.e. early sepsis or ARDS. Considering
these calculations, a 1000^2000 nmol min31 HOCl
infusion, as used in the present study, is regarded
as an adequate dosage. The used neutrophil cell
counts (between 300 and 3000 Wl31) reach physiolog-
ical levels as well. As we found certain e¡ects due to
the used dosages, even stronger functional altera-
tions may be expected under the conditions of real
in£ammation.
The preparation of the used amounts of neutro-
phils from rabbit would require peritoneal lavage
after intraperitoneal endotoxin application. Because
this procedure leads to a premature activation of the
prepared cells, we used human cells, prepared from
peripheral blood. Considering the mean diameter of
human neutrophils and rabbit pulmonary capillaries
[39] and the fact that there is no immunological in-
teraction between human neutrophils and rabbit lung
tissue, the use of human neutrophils in the used iso-
lated lung seems to be a feasible model.
Both models of neutrophil-derived oxidative stress,
HOCl infusion, and stimulation of neutrophils, in-
duce comparable e¡ects in the used isolated rabbit
lung preparation. Both evoke an increase in PAP and
vascular permeability. However, there are some
quantitative di¡erences: (1) The predominant e¡ect
of HOCl infusion was a remarkable increase in Kf ;c
and vW. The pressure response was signi¢cant, but
moderate. In contrast, stimulated PMN evoked a
more pronounced pressure response accompanied
by at least slight chances in vascular permeability.
(2) The pressure rise due to HOCl administration
started late, while stimulated neutrophils caused an
early pressure response. (3) Changes in PAP and
vascular permeability due to HOCl administration
occurred simultaneously, whereas the changes in
the vascular permeability caused by neutrophil stim-
ulation were observed after PAPmax was reached.
HOCl as a highly reactive oxidant acts very locally.
This may be the possible explanation for these di¡er-
ences: infused HOCl a¡ects primarily the endothelial
cell function, it may cause predominant and early
changes in vascular permeability. Neutrophils, how-
ever, migrate into the perivascular compartment.
Once stimulated, they primarily a¡ect vascular
smooth muscle cells that regulate vascular tone. In
conclusion, the quantitative di¡erences between the
models may be explained by the di¡erent compart-
ments in which the oxidant acts on di¡erent targets,
While the qualitative e¡ects are comparable. This
hypothesis is also supported by the equal inhibitory
e¡ect of ASA on the pressure response in both mod-
els.
4.2. E¡ect of ASA on oxidative stress-induced lung
injury
ASA (aspirin) is a commonly used inhibitor of AA
cyclooxygenase metabolism and very well known in
clinical practice. It has been reported to prevent the
e¡ect of hydrogen peroxide in combination with sub-
threshold concentrations of AA inducing platelet ag-
gregation due to TXA2 formation in a dose-de-
pendent manner [40]. Inhibitory e¡ects of ASA on
neutrophil hydrogen peroxide formation via trans-
formation to dihydroxybenzoates (DHB) are de-
scribed as well [41]. Furthermore, there are data
that suggest a direct inhibitory action of non-steroi-
dal antiphlogistics on the MPO^hydrogen peroxide^
chloride system with consecutive inhibition of HOCl
formation [42]. As shown in Figs. 2 and 3, MPO
activities do not di¡er between the PMN and the
ASA group in the experiments with stimulated
PMN. ASA evoked an inhibitory e¡ect also in ex-
periments with continuous HOCl infusion, in which
the HOCl-induced e¡ects were independent from
MPO activity. Therefore, a direct inhibitory e¡ect
of ASA on MPO activity, as well as an inhibitory
e¡ect on hydrogen peroxide release are not likely to
explain the observed e¡ects of ASA in both models.
Finally, because of its chemical structure, ASA is not
expected to exhibit activity as an antioxidative scav-
enger. For those reasons, only the action as irrevers-
ible cyclooxygenase inhibitor remains as a possible
explanation for the observed e¡ects. There are no
data in the available literature suggesting that the
oxygen burst of stimulated neutrophils is dependent
on leukocyte cyclooxygenase activation. As shown in
the present study, ASA causes an inhibitory e¡ect on
oxidative stress-induced lung injury. Thus, activation
of AA cyclooxygenase metabolism in compartments
other than neutrophils has to be supposed. Pulmo-
nary endothelial cells, type II cells, and resident
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monocytes and macrophages are possible targets, in
which this cyclooxygenase activation may occur.
4.3. Cyclooxygenase activation due to oxidative stress
The mechanisms by which cyclooxygenase is acti-
vated due to HOCl-mediated oxidative stress remain
unclear. The biological importance of the cyclooxy-
genase pathway is essentially dependent on free fatty
acid supply. For example, there are three di¡erent
models considered in literature, by which hydrogen
peroxide in£uences the free fatty acid pools: (1) The
levels of free unesteri¢ed AA, the main substrate of
cyclooxygenase, are augmented by a dose-dependent
inhibition of the incorporation of AA into the mem-
brane phospholipids without a¡ecting the catalyzing
enzymes coenzyme A synthase and acyltransferase in
alveolar macrophages. Simultaneously, a remarkable
depletion of ATP required for the synthesis was ob-
served, suggesting this is the mean, by which oxida-
tive stress inhibits acylation and therefore consecu-
tive incorporation of AA [43]. (2) Hydrogen peroxide
is reported to elevate cellular cAMP levels without
a¡ection to the cellular content of cGMP and with
consecutive functional relaxation in isolated canine
bronchi [44], whereas in isolated rabbit intrapulmo-
nary arteries cGMP levels are elevated due to hydro-
gen peroxide which leads to a vasodilatation [45].
Hydrogen peroxide-induced vascular leakage is sig-
ni¢cantly inhibited by elevation of cAMP levels in
isolated rabbit lungs using both, activators of adeny-
late cyclase and inhibitors of phosphodiesterase [46].
Because of their various regulatory capacities includ-
ing the maintenance of cytoplasmatic calcium ho-
meostasis, cyclic monophosphates may mediate AA
metabolism by a calcium-dependent activation of
protein kinase C and the consecutive activation of
several phospholipases, especially the phospholipase
A2. (3) A direct stimulatory e¡ect on the phospholi-
pase A2 is described for hydrogen peroxide in com-
bination with subthreshold doses of AA in platelets
[40].
For HOCl, only the cellular energy depletion with
consecutive low levels of ATP is well characterized
for several cell systems [47]. Against this background,
a pulmonary energy depletion with consecutive re-
duction of AA uptake into phospholipids due to
HOCl-induced oxidative stress seems to be a very
likely explanation for the observed disturbances
with pulmonary artery pressure rise and non-cardiac
edema formation.
In conclusion, this study provides evidence, that
HOCl is a useful model of neutrophil-derived oxida-
tive stress mediated by a AA cyclooxygenase metab-
olism. The mechanism by which AA metabolism is
activated still needs further investigation.
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